Saquibal, Hanna Kim .

HRN: 27-19-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2025
CEFUROXIME 1.5GM (VIAL)
07/24/2025
07/25/2025
IV
1.5gm
Q8hr X 3 Doses
Sp NSVD With RMLE; UTI
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines